Skip to content

Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid on a PRN Basis

Adjunct Use of the Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid-containing Medication on a PRN Basis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02964000
Enrollment
75
Registered
2016-11-15
Start date
2016-11-30
Completion date
2017-12-31
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Pain, Low level laser therapy, Sham, Chronic Pain, Opioid, Physical activity, Quality of sleep

Brief summary

Hypothesis: Use of high level vs low level cold laser treatments will reduce chronic pain and the need for PRN opioid-containing analgesic medications. Secondary Hypothesis: High level (vs low level) laser treatments will increase the patients level of physical activity and quality of sleep.

Detailed description

Previous studies with low level laser therapy have reported beneficial effects on the level of pain in patients with a variety of chronic pain conditions. We designed this controlled, double blind, randomized study to determine in the active laser group would have a reduction in the need for 'PRN pain medication'. Screening Testing 1. Urine-toxicology screen. 2. Assessment of level of activity and range of motion and functional capacity evaluation for upper and/ or lower extremity. 3. Current drug history and use of analgesic medications including both opioid and or non-opioid analgesic medications. 4. Drug history and current medications along with non-traditional alternative treatments such as (e.g. acupuncture, massage, herbal treatments, etc.) Protocol Outline After obtaining written informed consent, patients will be asked to complete all the pre-screening and entry questionnaires (e.g., SF-36). 11- point Verbal Rating Scale (VRS) for pain at rest and with physical activity (0= none to 10= severe), level of physical activity (0=inactive to 10= fully active), and quality of sleep (0=poor to 10=excellent). Current analgesic \[pain\] medications both daily and PRN medications. Randomized into active (Phoenix Thera-Lase \[ PTL\]) or Low level PTL group using a computer generated random numbers table. Treatment Sessions After obtaining written informed consent for participating in the study and signing the standard HIPPA forms, the patient will be asked to describe the location of their current pain symptoms. Pre-treatment baseline assessments VRS for pain at rest and with physical activity (e.g. walking, climbing stairs) Kinesiology functional capacity evaluation (FCE) for upper and/ or lower extremities or low back (depending on location of pain). Current opioid and non-opioid analgesic medication usage Clinical opioid withdrawal scale (COWS) at baseline (the COWS will be repeated at the end of the 1st, 2nd, and 3rd week of treatments). Treatment sessions - Active or low level therapy for 20 - 40 min on Monday, Wednesday, and Friday for 3 weeks. Post- treatment sessions VRS for pain at rest and with ambulation immediately after each treatment After the end of 3-week treatment period Repeat pre-screening questionnaires. Kinesiology functional capacity evaluation (FCE) for upper and/ or lower extremities or low back (depending on location of pain). Long-term Follow Up 30-days after the last treatment session, a standardized follow-up questionnaire will be administered.

Interventions

DEVICELow level 1 Watt

The Phoenix Thera-Lase System will be on 1 watt

DEVICEPhoenix Thera-Lase System 42

The Phoenix Thera-Lase System will be on 42 watts

DEVICEPhoenix Thera-Lase System 74

The Phoenix Thera-Lase System will be on 74 watts

Sponsors

Phoenix Thera-lase Systems, LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Male or female patients * 25-65 years of age * taking oral opiate-containing analgesic medication on a PRN * patient with chronic pain related to an accident, injury or major surgery occurring within the past three years * Patients with a potentially treatable pain condition * Patient wiling to complete a daily diary for recording their pain score, activity level, quality of sleep and all pain-related medications for the three-week study period

Exclusion criteria

* Use of any opioid-containing pain medications for more than three years * History of alcohol or drug abuse, or drug-seeking behavior * Previous treatment for drug abuse in detox center or hospital * Current psychiatric condition which require centrally- active medications * Current excessive use of alcohol * Any unstable medical conditions (e.g. coronary artery disease, hepato-renal or pulmonary disease) * Patients not capable of consenting for themselves * Pregnant women * Women of child bearing potential not using acceptable birth control methods.

Design outcomes

Primary

MeasureTime frame
Reduce chronic pain1 month
reduce of opioid analgesic dosage.one month

Secondary

MeasureTime frameDescription
Level of physical activity1 monthIt will be assessed with a questionnaire
Quality of sleepone monthIt will be assessed with a questionnaire

Countries

United States

Contacts

Primary ContactPaul F White, PhD, MD
paul.white@cshs.org214-770-3775
Backup ContactOfelia Loani Elvir Lazo, MD
loanidoc@yahoo.com310-721-0590

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026